J. Hagan Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$737K Buy
802
+43
+6% +$43.6K 0.4% 37
2025
Q4
$816K Buy
759
+34
+5% +$32.5K 0.45% 39
2025
Q3
$553K Buy
725
+69
+11% +$51.3K 0.34% 49
2025
Q2
$500K Sell
656
-49
-7% -$38.1K 0.34% 52
2025
Q1
$544K Buy
+705
New +$587K 0.44% 33

Other funds holding LLY

J. Hagan Capital's LLY Position: Q1 2026 in Review

J. Hagan Capital increased its Eli Lilly (LLY) stake by 5.7% in Q1 2026, buying an estimated $43.6K and bringing the position to 802 shares worth $737K. The position accounts for 0.4% of the portfolio, ranked #37.

J. Hagan Capital first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $816K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • J. Hagan Capital held 802 shares of Eli Lilly worth $737K as of Q1 2026.
  • J. Hagan Capital bought 43 Eli Lilly shares in Q1 2026, an estimated $43.6K.
  • Eli Lilly made up 0.4% of J. Hagan Capital's portfolio in Q1 2026, its #37 holding.
  • J. Hagan Capital first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • J. Hagan Capital's Eli Lilly position peaked at $816K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on J. Hagan Capital's 13F filing for Q1 2026, filed 13 May 2026.